Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein (NASDAQ: HSIC) announced its successful Cares Hygiene Pack Program, aiding over 27,000 Ukrainians during the humanitarian crisis. Health care clients purchased over 200 hygiene packs, including essentials like toothbrushes and soap, assembled by more than 300 Team Schein Members across various locations, including the U.S. and Europe. Notable partners, MedShare and International Medical Corps, supported distribution in Ukraine and Poland. This initiative reflects Henry Schein’s commitment to emergency preparedness and enhancing the health and dignity of those affected.
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions to dental and medical practitioners, announced its participation in two key investor conferences. The Goldman Sachs Healthcare CEOs Unscripted Conference will take place on January 5, 2023, at 10:35 a.m. Eastern time. Following this, the 41st Annual J.P. Morgan Healthcare Conference is scheduled for January 11, 2023, at 9:00 a.m. Pacific time. Live webcasts of these presentations will be available on the company's investor relations site.
Henry Schein (Nasdaq: HSIC) announced a definitive agreement to acquire a majority stake in Biotech Dental S.A.S., a fast-growing provider of clinical software and oral surgery products based in France. The acquisition aims to expand Henry Schein's offerings in key dental categories, including implants and aligners. The transaction, subject to regulatory approvals, is expected to be slightly dilutive to 2023 earnings per share, primarily due to non-cash acquisition accounting adjustments. Biotech Dental reported approximately $100 million in revenue for 2021.
Henry Schein (NASDAQ: HSIC) recently celebrated the 24th annual Holiday Cheer for Children program, aiding over 1,700 individuals in need across multiple countries including the U.S., Australia, and Canada. Team Schein Members donated toys, clothing, and gift cards valued for 500 local children, supported by the Henry Schein Cares Foundation. The initiative focuses on uplifting families during the holiday season, showcasing the company's commitment to community welfare and social responsibility. Collaborations with 10 social service organizations enhance the program's outreach.
Henry Schein One has launched Dentrix Detect AI, an AI-driven X-ray analysis tool in collaboration with VideaHealth, aimed at enhancing dental practices. This integration allows for real-time clinical decision support and simplifies workflows by automatically analyzing images without the need for manual import/export. Dentists can now offer immediate feedback and treatment recommendations to patients, improving case acceptance rates. The software, currently available to qualified Dentrix users, leverages VideaHealth’s FDA-cleared detection capabilities to ensure precise diagnostics.
Henry Schein, Inc. (NASDAQ: HSIC) showcased its products at the 2022 Greater New York Dental Meeting, emphasizing solutions for enhancing practice efficiency and patient experience.
The company launched the AI-enabled X-ray analysis tool, Dentrix Detect AI, powered by VideaHealth, aimed at streamlining clinical decision-making for dentists.
Visitors can explore various technological solutions including laser systems, digital scanners, and software for practice management, marketing, and analytics, reflecting Henry Schein's commitment to innovation in dental care.
Henry Schein (Nasdaq: HSIC) has partnered with the American Association of Dental Office Management (AADOM) to present the Green Leader Award to Jennifer Z. Vickery, VP of Operations at Ocean Dental, recognizing her efforts in promoting sustainability across 15 clinics. Presented at the AADOM Conference in Scottsdale, Arizona, the award highlights her initiatives, including transitioning to paperless practices and implementing eco-friendly policies. AADOM aims to empower dental practices to reduce their environmental impact, a mission supported by Henry Schein.
Henry Schein, listed on Nasdaq as HSIC, announced its participation in three upcoming investor conferences. These include the Piper Sandler’s 34th Annual Healthcare Conference on November 30, 2022, at 9:00 a.m. ET, the Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. ET, and the Nasdaq 47th Investor Conference in London on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. ET. Presentations will be available via live webcast and replays on the company’s website.
Henry Schein reported third-quarter 2022 net sales of $3.1 billion, a 3.5% decline from Q3 2021. Internal sales growth, excluding PPE and COVID-19 products, rose 6.8% in local currencies. GAAP diluted EPS for the quarter was $1.09, down from $1.15 year-over-year, while non-GAAP diluted EPS increased to $1.15 from $1.10. The full-year 2022 non-GAAP diluted EPS guidance is narrowed to $4.79 to $4.87, reflecting a potential growth of 6% to 8% compared to 2021. The company expects full-year sales growth of 1.5% to 2.5%.
Henry Schein, trading under NASDAQ: HSIC, announces its participation in two investor conferences in November 2022. The first is Credit Suisse's 31st Annual Healthcare Conference on November 9 at the Terranea Resort, California, followed by Stifel's 2022 Healthcare Conference on November 15 at the Lotte New York Palace, New York City. Both presentations will be available via live webcast on the company's website and replays will be accessible afterward. Henry Schein is a leader in healthcare solutions, serving over 1 million customers globally.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
